
Thursday, October 20, 2022 3:40:35 PM
Some preclinical data from Refuge Bio https://jitc.bmj.com/content/8/Suppl_3/A86.2 https://jitc.bmj.com/content/9/Suppl_2/A162 https://jitc.bmj.com/content/9/Suppl_2/A164 https://jitc.bmj.com/content/8/Suppl_3/A458.2

Liked By
Spread the love. Be the first to like this post!
Recent GILD News
- Gilead Sciences Announces $3 Million in Grant Funding to Eight Organizations Addressing HIV Disparities in Rural U.S. Communities • Business Wire • 03/22/2023 04:00:00 PM
- Kite’s Yescarta® CAR T-cell Therapy Demonstrates a Statistically Significant Improvement in Overall Survival for Initial Treatment of Relapsed/Refractory Large B-cell Lymphoma • Business Wire • 03/21/2023 01:37:00 PM
- Gilead Exercises Option to License Nurix’s IRAK4 Targeted Protein Degrader Development Candidate, NX-0479 • GlobeNewswire Inc. • 03/20/2023 12:30:00 PM
- Gilead Exercises Option to License Nurix’s IRAK4 Targeted Protein Degrader Development Candidate, NX-0479 • Business Wire • 03/20/2023 12:30:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 03/14/2023 10:21:37 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 03/14/2023 04:03:53 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 03/02/2023 11:49:23 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/23/2023 09:23:43 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/23/2023 09:19:28 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/23/2023 09:10:55 PM
- Annual Report (10-k) • Edgar (US Regulatory) • 02/22/2023 09:20:52 PM
- Gilead Presents Positive Proof-of-Concept Data for Investigational Combination Regimen of Lenacapavir with Broadly Neutralizing Antibodies as a Potential Twice-Yearly Approach for the Treatment of HIV • Business Wire • 02/22/2023 04:21:00 PM
- Kite Completes Acquisition of Tmunity • Business Wire • 02/22/2023 02:00:00 PM
- Veklury® (Remdesivir) Reduced Risk of Mortality in Hospitalized COVID-19 Patients Across all Variant Time Periods in a Real World Study of More than 500,000 Hospitalized Patients • Business Wire • 02/21/2023 10:30:00 PM
- Gilead Presents New Data From HIV Cure Research Program and Collaborations Exploring Novel Investigational Combinations and Strategies • Business Wire • 02/21/2023 08:01:00 PM
- Trodelvy® Demonstrates Positive Efficacy Treating Both Platinum-Ineligible and Rapidly Progressing, Post-Platinum Metastatic Urothelial Cancer • Business Wire • 02/17/2023 02:00:00 PM
- Gilead Demonstrates Transformative Potential Impact Of Antiviral Innovation at CROI 2023 • Business Wire • 02/14/2023 01:45:00 PM
- Schedule 13g<br /> (sc 13g/a) • Edgar (US Regulatory) • 02/13/2023 08:35:26 PM
- Schedule 13g<br /> (sc 13g) • Edgar (US Regulatory) • 02/13/2023 07:53:09 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/09/2023 04:29:50 PM
- Kite’s Tecartus® CAR T-Cell Therapy Demonstrates Overall Survival Benefit in Three-Year Follow-up of Pivotal ZUMA-3 Trial in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia • Business Wire • 02/09/2023 12:15:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/07/2023 10:48:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/07/2023 08:50:56 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/06/2023 09:07:07 PM
- Gilead Gets FDA Expanded OK of Trodelvy in Pre-Treated HR+/HER2- Metastatic Breast Cancer • Dow Jones News • 02/03/2023 04:13:00 PM
FEATURED Lifecycle Assessment by Benchmark Shows TMC's NORI-D Nodule Project Could Outperform Land-Based Routes of Producing Nickel, Copper and Cobalt in Almost Every Impact Category Analyzed • Mar 22, 2023 1:44 PM
FEATURED Fineqia Announces Partnership with Paris Blockchain Week to Accelerate Digital Asset Innovation • Mar 22, 2023 10:03 AM
FEATURED E-Cite and ClearMarket Launch Nationwide EV Distribution Network Becoming the First All EV Dealership Opening in the Cerritos Auto Square, the World's Largest Automall • Mar 22, 2023 9:41 AM
Nextech3D.ai Announces Its AI-Powered SaaS Platform Toggle3D Experiences A +963% Jump in Users in 60-Days Crossing Over 1000 Users • NTAR • Mar 23, 2023 7:07 AM
Electromedical Announces $1.36M Net Proceeds from Building Sale to Fund WellnessPro Infinity ™ Launch and Convertible Note Retirement. • EMED • Mar 22, 2023 7:04 AM
HealthLynked Corp. Awarded Patent 11,600,395 for "Secure Patient Access via Healthcare Service Provider Specific Wireless Access Point" • HLYK • Mar 21, 2023 8:00 AM